Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIVA versus inhalational anesthesia for postoperative nausea and vomiting after laparoscopic obstetric surgery
PACTR202511762741637Phase 4Not yet recruiting
- Sponsor
- Mohamed Ashraf
- Start
- Nov 2025
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol, sevoflurane and desflurane in postoperative nausea and vomiting (PONV), sponsored by Mohamed Ashraf. Primary endpoints: Incidence of postoperative nausea and vomiting (0-24 hours) and Postoperative nausea and vomiting scoring system. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
propofolsevofluranedesflurane
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on PACTR202511762741637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202511762741637.